July 23, 2018 news: Biel's Actipatch musclularskeletin pain therapy added to Australia's Mundipharma pain portfolio. Chaching! It keeps adding up to increased revenues. August 15th report should be interesting as Actipatch gaining worldwide acceptance for alternative to addictive pain drugs.
(1)
(0)
BioElectronics Corporation (BIEL) Stock Research Links